Patient case competition 2025

Concept of the project

Submission period: 01 January 2025 – 31 March 2025

Patient case competition:

• Physicians can submit patient cases over a 3-month period.
• Patient cases that demonstrate the importance of goal-directed therapies in patient blood management (with a focus on the use of fibrinogen).

BeSARPP will organize the project:

(Belgian Society of Anesthesiology, Resuscitation, Perioperative medicine and Pain management)

• Cases will be sent directly to BeSARPP.
• Cases may not contain brand names.
• An independent steering committee will select 2 winners.
• Each winner will receive a grant of € 5 000,00.
• The best case will be presented on the BeSARPP Annual Meeting on 20-21 June.

Objective of the project:

• Increase awareness of the important role of fibrinogen and targeted therapies in patient blood management.
• Exercise for HCPs in reporting and describing a case.
• Content of the patient cases may be used and distributed by CSL Behring through the Bleed Academy website.

Grant:

• The grant can only be used for (pre-)clinical research or educational training.
• CSL Behring must give approval on the (pre-)clinical research/educational training, chosen by the winner, before the grant can be awarded. This approval is required to ensure that the money goes to an educational purpose.
• The grant cannot be disbursed directly to an HCP, but will be disbursed to an HCO.
• CSL Behring provides a sponsorship of € 10 000,00 to BeSARPP to cover the winners’ grant. The decision of winner and payment of the grant to the HCO lies entirely with the BeSARPP.

Important dates:

• Patient case submissions: 1 january 2025 – 31 March 2025. The application consists of the patient case + short CV HCP.
• Period of review by steering committee: 5 April 2025 – 5 May 2025.

Guidelines:

• the submitted patient cases must discuss the treatment of massive bleeding, and demonstrate the importance of goal-directed therapies and protocols in patient blood management (with a focus on the use of fibrinogen). 
• the disease area can be multiple (for example but not limited to: PPH, trauma, ICU, surgery, transplant)
• no brand names can be mentioned.

• You may use the ACTA guidelines. More information can be found here.

• Preferably with references: support the course of the case with literature/guidelines

• If possible, with images of test results (viscoelastic test, lab) or tables/figures from the literature

• No minimum number of slides/pages

• Here is also an example of a patient case: https://www.bleedacademy.be/patient-cases/

Note: this case is presented in a question-and-answer format by an external company; it is not intended to send it this way, but to provide the information to create it